Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors

Topics in Magnetic Resonance Imaging

Volumn 10, Issue 2, 1999, Pages 114-124

  Sugahara, Takeshi ^a,b   Korogi, Yukunori ^a   Shigematsu, Yoshinori ^a   Liang, Luxia ^a   Yoshizumi, Kazuhiro ^a   Kitajima, Mika ^a   Takahashi, Mutsumasa ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Shimonoseki Kosei Hospital   (Japan)

Author keywords

Blood volume; Brain neoplasms; Cerebral; Magnetic resonance; Susceptibility contrast

Indexed keywords

GADOLINIUM;

ANGIOGENESIS; ARTICLE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GLIOMA; HUMAN; INTRACRANIAL TUMOR; LYMPHOMA; MENINGIOMA; NEURINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 0032732584     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-199904000-00004     Document Type: Article

References (58)

1. DiChiro G. Positron emission tomography [18-F] fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986;22:360-71.
2. Alavi J, Alavi A, Charoluk J, et al. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 1988;62: 1074-8.
3. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
4. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
5. Kallinowski F, Schlenger KH, Runkel S, et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res 1989;49:3759-64.
6. Frahm J, Hasse A, Matthaei D. Rapid three dimensional MR imaging using the FLASH technique. J Comput Assist Tomogr 1986;10: 363-8.
7. Cohen MS, Wesskoff RM. Ultra-fast imaging. Magn Resort Imaging 1991;9:1-37.
8. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1996;34:555-66.
9. Reinhold HS, Endrich B. Tumor microcirculation as a target for hyperthermia; review. Int J Hyperthermia 1986;2:111-37.
10. Song CW, Lokshina A, Rhee JG, Patten M, Levitt SH. Implication of blood flow in hyperthermic treatment of tumors. IEEE BME 1984;31:9-16.
11. Scatliff JH, Guinto FC Jr. Vascular patterns in cerebral neoplasms and their differential diagnosis. Semin Roentogenol 1971;6:59-69.
12. Scatliff JH, Radcliffe WB, Pittman HH, Park CH. Vascular structure of glioblastomas. AJR 1969;105:795-805.
13. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793-9.
14. Aronen HJ, Gazit IE, Luis DN, et al. Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 1994;191:41-51.
15. Sugahara T, Korogi Y, Kochi M. et al. Relationship of MR determined cerebral blood volume maps to histologic and angiographic vascularities of gliomas. AJR 1998;171:1479-86.
16. Russell D, Rubinstein L. Tumors of central neuroepithelial origin. In: Rubenstein LJ, ed. Pathology of tumors of the nervous system. Baltimore, MD: Williams & Wilkins, 1989;83-350.
17. Black PM. Brain tumors. N Engl J Med 1991;324:1471-6, 1555-64.
18. Burger PC, Vogel S, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Cancer 1985;56:1106-11.
19. Nelson DF, Nelson JS, Davis DR, et al. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J Neurol Oncol 1985;3:99-103.
20. Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988;38:1371-4.
21. Coffey RJ, Lunsford LD, Taylor FH. Survival after sterotactic biopsy of malignant gliomas. Neurosurgery 1988;22:465-73.
22. Greenberg MS. Handbook of neurosurgery. Lakeland, FL: Greenberg Graphics, 1994.
23. Siewert B, Patel MR, Mueller MF, et al. Brain lesions in patients with multiple sclerosis: Detection with echo-planar imaging. Radiology 1995;196:765-71.
24. Koeller KK, Smirniotopoulos JG, Jones RV, Smirniotopoulos JG, Jones RV. Primary central nervous system lymphoma: Radiologic-pathologic correlation. Radiographics 1997;17:1497-526.
25. Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. Cancer 1994;74:1383-97.
26. DeAngelis LM. Primary central nervous system lymphoma as a secondary malignancy. Cancer 1991;67:1431-5.
27. Baumgartner JE, Rachlin JR, Beckstead JH, et al. Primary central nervous system lymphomas: Natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990;73:206-11.
28. Cordoliani YS, Derosier C, Pharaboz C, Jeanbourquin D, Schill H, Cosnard G. Primary brain lymphoma in AIDS: 17 cases studied by MRI before stereotaxic biopsies. J Radiol 1992;73:367-76.
29. Roman-Goldstein SM, Goldman DL, Howieson J, Belkin R, Neuwelt EA. MR of primary CNS lymphoma in immunologically normal patients. AJNR 1992;13:1207-13.
30. O'Malley JP, Zeissman HA, Kumar PN, Harkness BA, Tall JG, Pierce PF. Diagnosis of intracranial lymphoma in patients with AIDS: Value of 201TI single-photon emission computed tomography. AJR 1994;163:417-21.
31. DeAngelis LM. Cerebral lymphoma presenting as a nonenhancing lesion on computed tomographic/magnetic resonance scan. Ann Neurol 1993;33:308-11.
32. Kupfer MC, Zee CS, Colletti PM, Boswell WD, Rhodes R. MRI evaluation of AIDS-related encephalopathy: toxoplasmosis vs. lymphoma. Magn Reson Imaging 1990;8:51-7.
33. Johnson BA, Fram EK, Johnson PC, Jacobowitz R. The variable MR appearance of primary lymphoma of the central nervous system: Comparison with histopathologic features. AJNR 1997; 18:563-72.
34. Brant-Zawadzki M, Berry I, Osaki L, Brasch R, Murovic J, Norman D. Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions. AJR 1986;147:1223-30.
35. Sugahara T, Korogi Y, Shigematsu Y, et al. Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 1999;23:232-7.
36. Jiddane M, Nicoli F, Diaz P, et al. Intracranial malignant lymphoma. Report of 30 cases and review of the literature. J Neurosurg 1986; 65:592-9.
37. Scatliff JH, Guinto FC Jr, Radcliffe WB. Vascular patterns in cerebral neoplasms and their differential diagnosis. Semin Roentogenol 1971;6:59-69.
38. Scatliff JH, Radcliffe WB, Pittman HH, Park CH. Vascular structure of glioblastomas. AJR 1969;105:795-805.
39. Helle TL, Britt RH, Colby TV. Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J Neurosurg 1984;60:94-103.
40. Frank G, Ferracini R, Spagnolli F, et al. Primary intracranial lymphomas. Surg Neurol 1985;23:3-8.
41. Helle TL, Britt RH, Colby TV. Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J Neurosurg 1984;60:94-103.
42. Kawakami Y, Tabuchi K, Ohnishi R, Asari S, Nishimoto A. Primary central nervous system lymphoma. J Neurosurg 1985;62:522-7.
43. Maeda M, Itoh S, Kimura H, et al. Vascularity of meningiomas and neuromas: Assessment with dynamic susceptibility-contrast MR imaging. AJNR 1994;163:181-6.
44. Fujii K, Fujita N, Hashimoto T, Miura T, Kozuka Y. Neuromas and meningiomas: Evaluation of early enhancement with dynamic MR imaging. AJNR 1992;43:1215-20.
45. Nagele T, Petersen D, Klose U, et al. Dynamic contrast enhancement of intracranial tumors with snapshot-FLASH MR imaging. AJNR 1993;14:89-98.
46. Dean BL, Flom RA, Wallace RC, et al. Efficacy of endovascular treatment of meningiomas: Evaluation with matched samples. AJNR 1994;15:1675-80.
47. Wakhloo AK, Juengling FD, Van Velthoven V, Schumacher M, Henning J, Schwechheimer K. Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: Assessment of two embolization techniques. AJNR 1993;14:571-82.
48. Bruening R, Wu RH, Yousry TA, et al. Regional relative blood volume MR maps of meningiomas before and after partial embolization. J Comput Assist Tomogr 1998;22:104-10.
49. Gutin PH, Liebel SA, Sheline GE, et al. Radiation injury to the nervous system. New York: Raven Press, 1991.
50. Valk PE, Dillon WP. Radiation injury of the brain. AJNR 1991;12: 45-62.
51. Curran WJ, Hecht-Leavitt C, Schut L, Zimmerman RA, Nelson DF. Magnetic resonance imaging of cranial radiation lesions. Int J Radiat Oncol Biol Phys 1987;13:1093-8.
52. Grossman RI, Hecht-Leavitt CM, Evans SM, et al. Experimental radiation injury: Combined MR imaging and spectroscopy. Radiology 1988;169:305-9.
53. Rosen BR, Aronen HJ, Kwong KK, Belliveau JW, Hamberg LM, Fordham JA. Advances in clinical neuroimaging: Functional MR imaging techniques. Radiographics 1993;13:889-96.
54. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: Evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233-8.
55. Gobbel GT, Seilhan TM, Fike JR. Cerebrovascular response after interstitial irradiation. Radiat Res 1992;130:236-40.
56. Miyata T, Banno T, Mase M, et al. Dual dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 1997;7:230-5.
57. Haraldseth O, Jones RA, Müller TB, Fahlvik AK, Oksendal AN. Comparison of dysprosium DTPA BMA and superparamagnetic iron oxide particles as susceptibility contrast agents for perfusion imaging of regional cerebral ischemic in the rat. J Magn Reson 1996;6:714-7.
58. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-74.